← All trials
NCT05896371
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 29, 2024
- Primary completion
- Jun 15, 2028
- Completion date
- Jun 15, 2032
- First posted
- Jun 9, 2023
- Last posted
- Nov 22, 2023
- Enrollment
- 500
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Laval UniversityLead sponsor
- Laval UniversityOverall official - principal investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.